Humana (NYSE:HUM) Issues FY 2025 Earnings Guidance

Humana (NYSE:HUM) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 16.250-16.250 for the period, compared to the consensus estimate of 16.410. The company issued revenue guidance of -.

Analysts Set New Price Targets

A number of brokerages recently issued reports on HUM. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $290.00 target price on shares of Humana in a research report on Wednesday, February 12th. Barclays lifted their price objective on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. Truist Financial boosted their target price on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research note on Monday, January 6th. StockNews.com downgraded shares of Humana from a “buy” rating to a “hold” rating in a report on Tuesday, March 18th. Finally, Morgan Stanley dropped their price objective on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a report on Wednesday, February 12th. Eighteen investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Humana presently has an average rating of “Hold” and a consensus price target of $285.68.

Humana Trading Up 0.2 %

HUM opened at $265.20 on Thursday. The firm’s fifty day moving average is $268.97 and its two-hundred day moving average is $272.62. The firm has a market cap of $32.01 billion, a PE ratio of 26.65, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. Humana has a twelve month low of $213.31 and a twelve month high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM) last announced its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Equities research analysts anticipate that Humana will post 16.47 EPS for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.33%. Humana’s payout ratio is 35.58%.

Hedge Funds Weigh In On Humana

A hedge fund recently bought a new stake in Humana stock. Revolve Wealth Partners LLC purchased a new position in shares of Humana Inc. (NYSE:HUM) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 798 shares of the insurance provider’s stock, valued at approximately $202,000. 92.38% of the stock is owned by institutional investors.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.